01.06.2009 | Clinical and Epidemiological Study
Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts
Erschienen in: Infection | Ausgabe 3/2009
Einloggen, um Zugang zu erhalten